Laura Estevez-Garcia
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The association of high body mass index with the safety and efficacy of sacituzumab govitecan in patients with metastatic triple-negative breast cancer from the ASCENT study.
Journal: ESMO open
Published: January 15, 2025
Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor-Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 15, 2023
Updating the role of obesity and cholesterol in breast cancer.
Journal: Breast cancer research : BCR
Published: March 03, 2019
Randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel in estrogen receptor-positive, HER2-negative patients with advanced breast cancer (NorBreast-231 trial).
Journal: Breast (Edinburgh, Scotland)
Published: October 30, 2018
Selecting postoperative adjuvant systemic therapy for early stage breast cancer: A critical assessment of commercially available gene expression assays.
Journal: Journal of surgical oncology
Published: December 12, 2016
Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 16, 2014
Impact of chemotherapy on telomere length in sporadic and familial breast cancer patients.
Journal: Breast cancer research and treatment
Published: October 06, 2014
Breast cancer management in the elderly.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: April 03, 2013
Multicenter, phase II, nonrandomized study of docetaxel plus trastuzumab every 21 days as the primary therapy in metastatic breast cancer overexpressing HER2.
Journal: Anti-cancer drugs
Published: November 25, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026